The U.S. Food and Drug Administration said a comprehensive review “found no increased” risk related to suicide among users of ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...

The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts ...

Eli Lilly's research and development head said on Monday the company will have plenty of supply to launch its ...

Weight-loss drug developer Viking Therapeutics CEO said on Monday that strategic interest in weight-loss drug deals is ...

For years, she seemed powerless against a fluctuating weight problem, until new medications, and a new attitude, gave Oprah ...

Cashews na small, kidney-shaped, pale yellow, and get rich, nutty flavour wey dey slightly sweeter dan peanuts.

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Rapid weight loss can increase gallstone formation, and hospitalists have reported more cases of biliary colic and ...

Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy ...

A new study finds that people who quit weight-loss medications, including GLP-1 drugs, regain weight four times faster than ...

The medication, available at a lower cost, is an alternative to injections and increases accessibility for patients, some ...